Beigene's "BeYueDa" completes its first sale in Beijing
China National Pharmaceutical Group Corporation (600511.SH) announced that, as the preferred distributor for BeiGene (06160.HK) for its new product "Baiyueda," it successfully completed the first delivery for BeiGene yesterday (14th). The medication arrived at China National Pharmaceutical Group's logistics in the afternoon yesterday and, with the cooperation and coordination of relevant departments such as the procurement center, Beijing direct sales center, and China National Pharmaceutical Group logistics, was delivered to the designated DTP pharmacy within 3 hours after arrival
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments